Research Article
Prevalence and Risk Factors of Cytopenia in HIV-Infected Patients before and after the Initiation of HAART
Table 4
The proportion of cytopenias at baseline and 6, 12, and 24 months after HAART.
| | Cytopenia | Baseline | At 6 months of HAART | At 12 months of HAART | At 24 months of HAART |
| | Neutropenia | 285 (46.6%) | 97 (18%) | 92 (15.1%) | 69 (11.3%) | | Anemia | 349 (57.1%) | 91 (14.9%) | 56 (9.2%) | 48 (7.9.%) | | Thrombocytopenia | 118 (19.3%) | 27 (4.4%) | 26 (4.3%) | 15 (2.5%) | | Unicytopenia | 483 (79.1%) | 155 (25.4%) | 133 (21.8%) | 108 (17.7%) | | Bicytopenia | 111 (18.2%) | 21 (3.4%) | 16 (2.6%) | 12 (2%) | | Pancytopenia | 16 (2.6%) | 6 (1%) | 3 (0.5%) | 1 (0.2%) |
|
|
